Remove business pharmaceuticals-industry
article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

article thumbnail

STAT+: Pharma’s reputation with patient groups is sliding again thanks to prices and shortages

STAT

The pharmaceutical industry saw its reputation slip last year among patient advocacy groups thanks to growing concern about the rising prices for medicines and a lack of confidence prompted by increasing shortages, according to a new survey.

286
286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional

STAT

In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription drug pricing. At the time, such laws were pursued by several states as a way to force the pharmaceutical industry to justify price hikes that were straining budgets.

article thumbnail

STAT+: White House is told the big three PBMs are ‘everything wrong with this industry’

STAT

As part of its battle to blunt the growing cost of medicines, the White House on Monday held a so-called listening session in hopes of finding ways to rein in big pharmacy benefit managers, which occupy an opaque but crucial role in pharmaceutical pricing in the U.S.

354
354
article thumbnail

STAT+: Takeda is fourth big company to leave BIO since December

STAT

WASHINGTON — Takeda Pharmaceuticals has left the biotechnology industry’s main lobbying group, the fourth departure of a major member since December, the company confirmed.

307
307
article thumbnail

STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more

STAT

Rise and shine, everyone, another busy day is on the way. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs. WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the U.S.

article thumbnail

STAT+: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom. rights to the drug.